Evidence map›Paper›PMID 23302686›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Cardiomyocyte proliferation contributes to heart growth in young humans.

Mariya Mollova, Kevin Bersell, Stuart Walsh, Jainy Savla, Lala Tanmoy Das, Shin-Young Park, Leslie E Silberstein, Cristobal G Dos Remedios, Dionne Graham, Steven Colan and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 428 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
428citing papers in PubMed, 1 pooled it
26.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

428 citing papers in PubMed, 1 synthesis or guideline pooled it, 739 citations in OpenAlex.

  1. Pooled it
  2. Postnatal Development Shapes the Cardiac Response to Milrinone.bioRxiv : the preprint server for biology · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Biologics for cardiovascular diseases: from bench to bedside.Signal transduction and targeted therapy · 2026
    Review
  9. Article
  10. Genome-wide association mapping and targeted loss of function studies identifyProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Mechanisms and Therapeutic Potential of Human Cardiomyocyte Proliferation.Journal of cardiovascular development and disease · 2026
    Review
  16. Article
  17. Article
  18. Article
  19. Placental insufficiency disrupts cardiomyocyte ploidy and cell cycle fate in growth-restricted fetal sheep.American journal of physiology. Regulatory, integrative and comparative physiology · 2026
    Article
  20. Article

368 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Mariya MollovaDepartment of Cardiology, Boston Children's Hospital, Boston, MA 02115, USA.
Kevin Bersell
Stuart Walsh
Jainy Savla
Lala Tanmoy Das
Shin-Young Park
Leslie E Silberstein
Cristobal G Dos Remedios
Dionne Graham
Steven Colan
Bernhard Kühn
Boston Children's Hospital · USBoston University · USHarvard University · USUniversity of Sydney · AUVanderbilt University · US

Funding

Myofibril disassembly during neonatal heart muscle cell proliferationR01HL106302 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KUHN, BERNHARD · 2011 to 2015
$2.1M
Periostin in Myocardial Injury and RegenerationK08HL085143 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI KUHN, BERNHARD · 2009 to 2013
$645k
NHLBI NIH HHS K08 HL085143NHLBI NIH HHS R01 HL106302
6 · The paper itself

Abstract

The human heart is believed to grow by enlargement but not proliferation of cardiomyocytes (heart muscle cells) during postnatal development. However, recent studies have shown that cardiomyocyte proliferation is a mechanism of cardiac growth and regeneration in animals. Combined with evidence for cardiomyocyte turnover in adult humans, this suggests that cardiomyocyte proliferation may play an unrecognized role during the period of developmental heart growth between birth and adolescence. We tested this hypothesis by examining the cellular growth mechanisms of the left ventricle on a set of healthy hearts from humans aged 0-59 y (n = 36). The percentages of cardiomyocytes in mitosis and cytokinesis were highest in infants, decreasing to low levels by 20 y. Although cardiomyocyte mitosis was detectable throughout life, cardiomyocyte cytokinesis was not evident after 20 y. Between the first year and 20 y of life, the number of cardiomyocytes in the left ventricle increased 3.4-fold, which was consistent with our predictions based on measured cardiomyocyte cell cycle activity. Our findings show that cardiomyocyte proliferation contributes to developmental heart growth in young humans. This suggests that children and adolescents may be able to regenerate myocardium, that abnormal cardiomyocyte proliferation may be involved in myocardial diseases that affect this population, and that these diseases might be treatable through stimulation of cardiomyocyte proliferation.

Indexed as

AdolescentAdultCell CycleCell EnlargementCell ProliferationChildChild, PreschoolFemaleFibrosisHeartHumansInfantInfant, NewbornMaleMiddle AgedMyocardium

Identifiers

PMID23302686
PMCPMC3557060
OpenAlexW2059062907

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.